Resimac Group Limited (ASX:RMC)
Australia · Delayed Price · Currency is AUD | Market Cap | 328.09M -0.6% |
| Revenue (ttm) | 195.86M +46.8% |
| Net Income | 49.51M +77.7% |
| EPS | 0.12 +79.1% |
| Shares Out | 395.28M |
| PE Ratio | 6.68 |
| Forward PE | 5.98 |
| Dividend | 0.07 (8.43%) |
| Ex-Dividend Date | Mar 6, 2026 |
| Volume | 280,676 |
| Open | 0.8400 |
| Previous Close | 0.8350 |
| Day's Range | 0.8250 - 0.8400 |
| 52-Week Range | 0.8100 - 1.2250 |
| Beta | 1.38 |
| Analysts | Hold |
| Price Target | 1.12 (+34.94%) |
| Earnings Date | Jun 9, 2026 |
About Resimac Group
Resimac Group Limited provides residential mortgage and asset finance lending products in Australia and New Zealand. The company operates through Home Loan Lending business, New Zealand Lending, and Asset Finance Lending segments. It offers prime and specialist lending products; SME/commercial finance products; and home, equipment, secured, novated leasing, and car loans. It also provides mortgage originator and trustee, lender, mortgage manager and broker, consumer and commercial lending, managed investment trust, and LMI captive insurer servi... [Read more]
Financial Performance
In fiscal year 2025, Resimac Group's revenue was 163.59 million, an increase of 11.08% compared to the previous year's 147.27 million. Earnings were 34.58 million, a decrease of -0.02%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for RMC stock is "Hold." The 12-month stock price target is $1.12, which is an increase of 34.94% from the latest price.
News
Resimac Group Earnings Call Transcript: H1 2026
Strong earnings growth in 1H 2026 driven by higher lending volumes, improved margins, and disciplined cost control. Credit performance improved, with lower arrears and impairment charges, while capital management enabled increased dividends and full repayment of corporate debt.
Resimac Group Quarterly report: H1 2026
Resimac Group has published its H1 2026 quarterly earnings report on February 24, 2026.
Resimac Group Slides: H1 2026
Resimac Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 24, 2026.
Resimac Group Transcript: AGM 2025
The AGM highlighted strong financial growth, a major acquisition, and a focus on digital transformation and AI-driven efficiency. All resolutions, including director re-elections and the remuneration report, were passed with strong shareholder support.
Resimac Group Earnings Call Transcript: H2 2025
Strong FY25 results with 13% growth in normalised operating profit, AUM up to $15.9B, and a successful $1.5B auto portfolio acquisition. Higher impairments impacted net profit, but cost and margin management, plus technology investment, position the group for sustainable growth.
Resimac Group Annual report: H2 2025
Resimac Group has published its H2 2025 annual report on August 27, 2025.
Resimac Group Slides: H2 2025
Resimac Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 27, 2025.
ASX 200 LIVE: Mayne Pharma shares plunge; CBA hits record; JHX sales, earnings slip amid AZEK buy; ASIC sues Resimac, sharemarket rises
Shares lift; CBA resets intraday record, tops $176; Mayne Pharma-Cosette tie-up hangs in balance; Nufarm plunges; James Hardie drops 5pc. Follow live.